| Literature DB >> 25903365 |
Olugbenga K Popoola1, Jeanine L Marnewick2, Fanie Rautenbach3, Farouk Ameer4, Emmanuel I Iwuoha5, Ahmed A Hussein6.
Abstract
Ten flavonoid-related structures viz. heliteretifolin (1), isoxanthohumol (2), 2',4',6'-trihydroxy-3'-prenylchalcone (3), isoglabranin (4), glabranin (5), 7-methoxy-isoglabranin (6), quercetin (7), 4'-methoxyquercetin (8), 4'-methoxykaempferol (9) and mosloflavone (10) were isolated from a H. teretifolium methanolic extract and identified. One of them (compound 1) is reported for the first time from a natural source, while compounds 6, 8-10 were isolated for the first time from the genus Helichrysum. The total extract of H. teretifolium showed potent antioxidant activity. When tested for total antioxidant capacity compound 3 possesses moderate biological activity compared to 2, which displayed some of the highest TEAC values (4529.01 ± 2.44; 4170.66 ± 6.72) µM TE/g, respectively. Compounds 7 and 8 demonstrated the highest inhibitory activities on Fe2+-induced lipid peroxidation (IC50 = 2.931; 6.449 µg/mL); tyrosinase (8.092; 27.573) and elastase (43.342; 86.548). Additionally, the total antioxidant capacities measured as FRAP (4816.31 ± 7.42; 3584.17 ± 0.54) µM AAE/g, and ORAC for hydroxyl radical (7.265 ± 0.71; 6.779 ± 3.40) × 106 and peroxyl radical (17.836 ± 2.90; 12.545 ± 5.07) × 103 µM TE/g were also observed for compounds 7 and 8, respectively. In conclusion, H. teretifolium total extract represents a rich source of bioactive constituents with potent antioxidant and moderate anti-tyrosinase and anti-elastase activities that can help to avert accumulation of free radicals in the body, and could therefore be good candidates for the prevention and/or treatment of skin-related conditions, such as aging. This is the first scientific report on the chemical and biological profile of H. teretifolium.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25903365 PMCID: PMC6272301 DOI: 10.3390/molecules20047143
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
1H- (400 MHz: m, J Hz) and 13C- (100 MHz) NMR spectral data of isolated compounds 1–6 in CDCl3.
| No. | 1 | 2 | 3 | 4 | 5 | 6 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13C | 1H | 13C | 1H | 13C | 1H | 13C | 1H | 13C | 1H | 13C | 1H | |
| 1 | 135.6 | 136.6 | 135.6 | |||||||||
| 2 | 128.2 | 7.58
| 129.23 | 7.55
| 128.3 | 7.53
| 79.07 | 5.37
| 79.1 | 5.30
| 79.3 | 5.38
|
| 3 | 128.9 | 7.37
| 129.88 | 7.29
| 128.6 | 7.31
| 43.44 | 3.05
| 43.4 | 3.05
| 43.5 | 3.05
|
| 2.79
| 2.71
| 2.78
| ||||||||||
| 4 | 130.0 | 7.37
| 131.0 | 7.29
| 129.7 | 7.31
| 195.9 | - | 195.5 | 195.8 | ||
| 5 | 128.9 | 7.37
| 129.9 | 7.29
| 128.6 | 7.31
| 161.2 | 161.1 | 161.3 | |||
| 6 | 128.2 | 7.58
| 129.2 | 7.55
| 128.3 | 7.53
| 107.0 | 108.6 | 110.1 | |||
| 7 | 163.8 | 164.2 | 165.5 | |||||||||
| 8 | 95.5 | 5.99
| 94.8 | 5.93
| 91.0 | 6.07
| ||||||
| 9 | 161.0 | 160.6 | 160.3 | - | ||||||||
| 10 | 102.9 | 102.3 | 102.9 | - | ||||||||
| 1' | 106.2 | - | 106.2 | 105.2 | 138.5 | 138.5 | 138.5 | - | ||||
| 2' | 167.3 | - | 164.7/164.6 | 163.4 | 126.1 | 7.30
| 126.1 | 7.42
| 126.1 | 7.37
| ||
| 3' | 95.5 | 6.03
| 109.2/109.1 | 106.7 | 128.8 | 7.30
| 128.7 | 7.42
| 128.9 | 7.37
| ||
| 4' | 160.6 | - | 160.9 | 162.0 | 128.8 | 7.30
| 128.7 | 7.42
| 128.9 | 7.37
| ||
| 5' | 103.3 | - | 91.6 | 6.05
| 94.4 | 5.80
| 128.8 | 7.30
| 128.7 | 7.42
| 128.9 | 7.37
|
| 6' | 155.7 | - | 164.3/163.9 | 160.0 | 126.1 | 126.1 | 7.42
| 126.1 | ||||
| α | 127.5 | 8.11
| 128.7/128.8 | 8.10/8.12
| 127.9 | 8.07
| ||||||
| β | 142.1 | 7.72
| 142.8/142.7 | 7.65
| 141.7 | 7.68
| ||||||
| CO | 192.8 | - | 193.8 | 192.9 | ||||||||
| 1'' | 117.0 | 6.58
| 22.0 | 3.22
| 21.1 | 3.33
| 20.9 | 3.21
| 21.0 | 3.24
| ||
| 2'' | 124.4 | 5.45
| 124.0 | 5.09
| 121.4 | 5.28
| 122.1 | 5.17
| 122.2 | 5.16
| ||
| 3'' | 77.9 | 136.6 | 135.7 | 132.4 | 131.7 | - | ||||||
| 4'' | 27.9 | 1.52 s | 26.0 | 1.48
| 25.8 | 1.74
| 25.6 | 1.63
| 25.8 | 1.65
| ||
| 5'' | 27.9 | 1.52 s | 17.9 | 1.60
| 17.9 | 1.79
| 17.7 | 1.72
| 17.7 | 1.75
| ||
| 1''' | 65.5 | 4.53
| ||||||||||
| 2''' | 118.8 | 5.56
| ||||||||||
| 3''' | 138.6 | - | ||||||||||
| 4''' | 25.8 | 1.77
| ||||||||||
| 5''' | 18.3 | 1.72
| ||||||||||
| 5-OH | - | 14.19
| 13.61
| 13.30
| 12.36
| 12.03
| ||||||
| 7-OMe | 56.6 | 3.70
| 55.8 | 3.81
| ||||||||
Figure 1Chemical structures of compounds 1–10 isolated from H. teretifolium.
Total antioxidant capacity of H. teretifolium constituents.
| Sample | Automated Oxygen Radical Absorbance Capacity (ORAC μM TE/g) | FRAP | TEAC | ||
|---|---|---|---|---|---|
| ROO. (μM/g × 103) | OH. (μM/g × 106) | Prooxidant (μM/g) | μM AAE/g | μM TE/g | |
| HT | 1.313 ± 7.54 | 3.016 ± 5.90 | 4.163 ± 0.83 | 511.89 ± 4.61 | 1179.60 ± 8.20 |
|
| 2.833 ± 3.88 | 2.998 ± 1.67 | 2.036 ± 2.98 | ND | ND |
|
| 3.113 ± 17.59 | 2.910 ± 6.00 | 3.601 ± 2.23 | 619.91 ± 1.97 | 4170.66 ± 6.72 |
|
| 5.025 ± 6.16 | 3.771 ± 3.02 | 4.704 ± 0.27 | 817.94 ± 4.26 | 4529.01 ± 2.44 |
|
| 1.063 ± 33.50 | 2.918 ± 4.13 | 3.947 ± 0.29 | 7.052 ± 3.76 | 43.17 ± 6.26 |
|
| 0.856 ± 17.35 | 2.997 ± 0.36 | 2.971 ± 1.10 | 67.79 ± 14.27 | 204.15 ± 2.04 |
|
| 3.854 ± 5.14 | 2.955 ± 3.41 | 3.799 ± 0.60 | 104.09 ± 4.64 | 519.25 ± 3.66 |
|
| 17.836 ± 2.90 | 7.265 ± 0.71 | 4.361 ± 0.78 | 4816.31 ± 7.42 | 1361.70 ± 1.98 |
|
| 12.545 ± 5.07 | 6.779 ± 3.40 | 8.963 ± 2.79 | 3584.17 ± 0.54 | 1009.01 ± 1.98 |
|
| 10.491 ± 0.97 | 3.675 ± 1.40 | 3.790 ± 1.15 | 191.47 ± 1.39 | 261.30 ± 4.02 |
|
| 2.403 ± 2.50 | 2.909 ± 8.41 | 6.482 ± 1.55 | 544.60 ± 6.98 | 699.66 ± 2.28 |
| EGCG | 14.970 ± 5.53 | 3.911 ± 4.65 | 6.483 ± 1.19 | 3326.45 ± 5.76 | 11545.4 ± 17.28 |
HT = H. teretifolium total extract ND = Not detected; EGCG = Epigallocatechin gallate.
The effects of H. teretifolium constituents on inhibition of Fe (II)-induced microsomal lipid peroxidation, tyrosinase and elastase activities.
| Sample | Inhibitory Activitis (IC50; μg/mL) * | ||
|---|---|---|---|
| Lipid Peroxidation | Tyrosinase | Elastase | |
| HT | 16.750 | 83.517 | 79.965 |
|
| >26.750 | >50 | >100 |
|
| >26.750 | >50 | >100 |
|
| 21.276 | >50 | >100 |
|
| >26.750 | >50 | >100 |
|
| >26.750 | >50 | >100 |
|
| 23.157 | >50 | >100 |
|
| 2.931 | 8.092 | 43.342 |
|
| 6.449 | 27.573 | >86.548 |
|
| 10.520 | 29.571 | >100 |
|
| 10.720 | 38.062 | >100 |
| EGCG | 0.929 | NA | NA |
| Kojic acid | NA | 3.425 | NA |
| Oleanolic acid | NA | NA | 9.806 |
* Data are given as IC50 with purified compounds screened at 26.750 μg/mL for inhibition of microsomal lipid peroxidation, while extract (HT) was screened at 100 μg/mL. Anti-tyrosinase activity for both extract and the purified compounds were screened at the effective concentration of 50 μg/mL, while 100 μg/mL was considered as optimum concentration for elastase assay.